An accelerated 6-month CMC timeline proposed for general biologics development. DP, drug product; DS, drug substance; GMP, good manufacturing practice; IND, investigational new drug application; MCB, master cell bank; Tox, toxicology study; UPB, unprocessed bulk; VC, viral clearance.